XML 33 R12.htm IDEA: XBRL DOCUMENT v3.19.3
6. Earnings Per Share
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Earnings Per Share

6. EARNINGS PER SHARE

 

The following table sets forth the computation of basic and diluted net loss per share of common stock for the three and nine months ended September 30, 2019 and 2018:

 

   For the Three Months Ended September 30, 
   2019   2018 
Net loss  $(349,316)  $(243,457)
           
Weighted average share outstanding basic   42,775,966    40,633,327 
           
Basic and diluted loss per share  $(0.01)  $(0.01)
           

 

   For the Nine Months Ended September 30, 
   2019   2018 
Net loss  $(1,676,357)  $(933,121)
           
Weighted average share outstanding basic   42,005,826    40,591,019 
           
Basic and diluted loss per share  $(0.04)  $(0.02)

 

Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and common share equivalents outstanding for the period. Common stock equivalents are only included when their effect is dilutive. The Company’s potentially dilutive securities which include stock options, convertible debt, convertible preferred stock and common stock warrants have been excluded from the computation of diluted net loss per share as they would be anti-dilutive. For all periods presented, there is no difference in the number of shares used to compute basic and diluted shares outstanding due to the Company’s net loss position.

 

The following outstanding common stock equivalents have been excluded from diluted net loss per common share for the three and nine months ended September 30, 2019 and 2018 because their inclusion would be anti-dilutive:

 

   September 30,
2019
   September 30,
2018
 
Warrants to purchase common stock   1,315,032    384,615 
Potentially issuable shares related to convertible notes payable   4,337,525    2,500,000 
Total anti-dilutive common stock equivalents   5,652,557    384,615